Keywords: Parkinson's disease, Market forecast, Europe
Drug candidates in pipeline offer potential for Parkinson's disease market, says Frost & Sullivan
Article | 09 December 2009
The Parkinson's disease therapeutics market in 2008 amounted to over $1 billion in the European Union, which includes total sales of carbidopa/ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
